Houston User Group Meeting
Tuesday, October 15, 2013 from 11:00 AM to 2:00 PM (CDT)
San Francisco, California
London, United Kingdom
Together with our friends from Intel, we would like to invite you to our user group meeting.
The big release of CLC Genomics Workbench 6.5 and CLC Genomics Server 5.5 offers completely new and intuitive ways of analyzing, comparing, and visualizing your sequencing data. At this meeting, we'll give you an overview of the powerful new features such as workflows, tracks, resequencing tools, and read mapper, to name a few.
Delivering this new and intuitive data requires the high-performance infrastructure of the Intel® Xeon® processor and the Intel® Enterprise Edition for Lustre* software designed to enable fully parallel I/O throughput across many clients, servers and storage devices. Space is limited so please sign up as soon as possible.
We're inviting users of CLC bio software mainly from the Houston area, so we hope you can join us to learn, share knowledge, and the opportunity to engage in discussions around sequence data analysis, together with experts from CLC bio and Intel.
If you have any questions, please feel free to contact us. We hope to see you at our user group meeting on October 15.
11:00 – Welcome, Richard Lussier
11:10 – What’s new at CLC bio, Rob Mervis
11:35 – Presentation by Dan Meyer, GenoSpace
11:50 – Presentation by Aysel Heckel, Ingenuity
12:05 - Presentation by Patricia Klein, Texas A&M
12:20 - CLC bio future roadmap
12:35 - CLC Consulting Overview, Cecilie Boysen
12:45 – Closing, Richard Lussier
12:50 - Lunch/Networking/Individual Demos
2:00 - Thanks - Meeting ends
CLC bio team
When & Where
CLC bio - a QIAGEN Company
We're the world's leading bioinformatics software developers and the only ones providing an analysis platform where both desktop and server software are seamlessly integrated and optimized for best performances.
Our wide range of analyses are available both through a user-friendly graphical user-interface as well as through command-line, allowing scientists to choose their preferred interface.